Alexion Pharmaceuticals' Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Alexion Pharmaceuticals careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Summary The Business Analysis team, which is a part of the Global Business Development Division, helps control the financial analysis, valuation, and structure of Alexion’s external pipeline investing activities. The team is a highly cent...
Posted: April 19, 2018, 3:34 am
Position Summary The Regional Account Manager, Neurology, San Diego, CA manages and develops long-term relationships with assigned physicians, extended prescribers, and other customers in the assigned territory. The Regional Account Manager will ...
Posted: April 18, 2018, 8:15 am
Position Summary A key member of the team responsible for delivery of quality systems oversight for activities to ensure commercial and/or clinical products are manufactured and distributed in accordance with all regulatory and corporate ...
Posted: April 17, 2018, 11:45 am
NY Territory - CT, RI, MA, ME, VT and NH Position Summary The Senior Medical Science Liaison (Sr. MSL) is field-based scientific expert that strategically supports the medical and scientific objectives of Alexion’s pr...
Posted: April 17, 2018, 9:03 am
Position Summary Leads the design, development and delivery of a comprehensive benefits strategy in support of the attraction, retention, and engagement of all employees globally. Develops, implements and administers cost-effective benef...
Posted: April 14, 2018, 7:32 am

Viewing page 1 of 36|Next Page

  Newsfeed | Subscribe  

[ALXN-G] View source version on businesswire.com: https://www.businesswire.com/news/home/20180420005757/en/ Contacts: Alexion Pharmaceuticals, Inc. Media: Arne Naeveke, PhD, 475-230-3774 or Investors: Susan Altschuller, PhD, 475-230-3534
Posted: April 20, 2018, 1:55 pm
In a statement, Alexion Pharmaceuticals (NASDAQ:ALXN) says the Patent Office ruling in Brazil presumably opening the door for the production of a generic form of top seller Soliris (eculizumab) refers to a "mailbox" patent that expired in 2015, ad...
Posted: April 20, 2018, 1:29 pm
Alexion Pharmaceuticals (ALXN) slid to a 10-month low Friday after reports emerged that Brazil's government will allow drugmakers to produce biologic copies of Alexion's blockbuster drug Soliris. But Alexion clarified in an email to Investor's Bus...
Posted: April 20, 2018, 1:00 pm
* ALEXION PHARMACEUTICALS INC - CONTINUES TO HAVE PATENT APPLICATIONS PENDING IN BRAZIL THAT WOULD PROVIDE ADDITIONAL PROTECTION TO SOLIRIS Source text for Eikon: Further company coverage: Our Standards:The Thomson Reuters Trust Principles.
Posted: April 20, 2018, 12:47 pm
NEW YORK, April 19, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on ADAP, AKBA, ALDR, and ALXN which can be accessed for free by signing up to www ...
Posted: April 19, 2018, 4:21 am

Viewing page 1 of 2|Next Page